Amgen Inc.
AMGN · NASDAQ
12/31/2024 | 12/31/2023 | 12/31/2022 | 12/31/2021 | |
|---|---|---|---|---|
| Revenue | $33,424 | $28,190 | $26,323 | $25,979 |
| % Growth | 18.6% | 7.1% | 1.3% | – |
| Cost of Goods Sold | $12,858 | $8,415 | $6,406 | $6,454 |
| Gross Profit | $20,566 | $19,775 | $19,917 | $19,525 |
| % Margin | 61.5% | 70.1% | 75.7% | 75.2% |
| R&D Expenses | $5,964 | $4,784 | $4,434 | $6,324 |
| G&A Expenses | $0 | $0 | $0 | $0 |
| SG&A Expenses | $7,096 | $6,179 | $5,414 | $5,368 |
| Sales & Mktg Exp. | $0 | $0 | $0 | $0 |
| Other Operating Expenses | $248 | $879 | $503 | $194 |
| Operating Expenses | $13,308 | $11,842 | $10,351 | $11,886 |
| Operating Income | $7,258 | $7,897 | $9,566 | $7,639 |
| % Margin | 21.7% | 28% | 36.3% | 29.4% |
| Other Income/Exp. Net | -$2,649 | -$42 | -$2,220 | -$938 |
| Pre-Tax Income | $4,609 | $7,855 | $7,346 | $6,701 |
| Tax Expense | $519 | $1,138 | $794 | $808 |
| Net Income | $4,090 | $6,717 | $6,552 | $5,893 |
| % Margin | 12.2% | 23.8% | 24.9% | 22.7% |
| EPS | 7.62 | 12.56 | 12.18 | 10.34 |
| % Growth | -39.3% | 3.1% | 17.8% | – |
| EPS Diluted | 7.56 | 12.49 | 12.11 | 10.28 |
| Weighted Avg Shares Out | 541 | 535 | 538 | 570 |
| Weighted Avg Shares Out Dil | 541 | 538 | 541 | 573 |
| Supplemental Information | – | – | – | – |
| Interest Income | $0 | $0 | $0 | $0 |
| Interest Expense | $3,155 | $2,875 | $1,406 | $1,197 |
| Depreciation & Amortization | $5,592 | $4,071 | $3,417 | $3,398 |
| EBITDA | $13,356 | $14,801 | $12,169 | $11,296 |
| % Margin | 40% | 52.5% | 46.2% | 43.5% |